Cardinal Health (CAH) Earnings: Adjusted EPS Sees High End of $6.75 to $7.00, Anticipates Consistent 2Q Medical Segment Profit

Cardinal Health on Smartkarma

Cardinal Health, a leading company in the medical and pharmaceutical industry, has been receiving positive analyst coverage on Smartkarma, an independent investment research network. According to research reports published by Baptista Research, a top independent analyst on the platform, Cardinal Health delivered a solid result in the last quarter, exceeding expectations and achieving significant milestones. The company saw a 10% increase in total revenue, primarily driven by its Pharma segment. Despite flat revenue in the Medical segment, Cardinal Health managed to beat expectations.

In another report by Baptista Research, Cardinal Health‘s pioneering NTrainer System 2.0, which is changing neonatal care forever, was highlighted as a major driver for the company’s success. The report states that Cardinal Health delivered a positive result and managed an all-around beat in the last quarter. The company’s Pharma segment showed remarkable profit growth of 13%, and it generated significant adjusted free cash flow. Cardinal Health has also been taking strategic actions to streamline its operations, optimize its organizational structure, and make fundamental leadership changes, which have been well-received by analysts on Smartkarma.

A look at Cardinal Health Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Cardinal Health, Inc. is a company that offers various products and services to healthcare providers and manufacturers. These services include distributing pharmaceuticals, manufacturing healthcare products, and providing consulting services. The company also develops drug delivery systems, packages pharmaceuticals, manufactures automated dispensing systems, and franchises retail pharmacies.

According to the Smartkarma Smart Scores, Cardinal Health has a positive long-term outlook. The company scored a 4 out of 5 for Resilience, indicating its ability to withstand economic downturns and maintain stable revenue. Additionally, Cardinal Health scored a 5 out of 5 for Momentum, which suggests strong growth potential in the future. While the company received lower scores for Value and Dividend, with scores of 0 and 2 respectively, it still scored a 2 out of 5 for Growth. This indicates that Cardinal Health has room for improvement in terms of value and dividend, but is still expected to experience growth in the future. Overall, the Smartkarma Smart Scores paint a promising picture for the long-term outlook of Cardinal Health.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma